Dexibuprofen Modified-Release Bilayer Tablets(Taizhou Overseas Pharma)

右布洛芬缓控释双层片(越洋医药)

Report date: 2025/08/08 13:41:55

Base Information

Drug NameDexibuprofen Modified-Release Bilayer Tablets(Taizhou Overseas Pharma)
Drug Alias NameDaxfen右旋布洛芬MovoneS-布洛芬(S)-(+)-Ibuprofen +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsHeadachePainFever +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHeadachePainFever +[8
Inactive IndicationsN/A

Other Information

ATC CodeN/A